Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 174

1.

The new and evolving pharmacotherapy of schizophrenia.

Emsley R, Oosthuizen P.

Psychiatr Clin North Am. 2003 Mar;26(1):141-63. Review.

PMID:
12683264
[PubMed - indexed for MEDLINE]
2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
3.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

PMID:
16707074
[PubMed - indexed for MEDLINE]
Free Article
4.

Impact of atypical antipsychotics on quality of life in patients with schizophrenia.

Awad AG, Voruganti LN.

CNS Drugs. 2004;18(13):877-93. Review.

PMID:
15521791
[PubMed - indexed for MEDLINE]
5.

Evidence-based pharmacotherapy of schizophrenia.

Emsley R, Oosthuizen P.

Int J Neuropsychopharmacol. 2004 Jun;7(2):219-38. Epub 2004 Apr 13. Review.

PMID:
15043765
[PubMed - indexed for MEDLINE]
6.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
[PubMed - indexed for MEDLINE]
7.

Selection of atypical antipsychotics for the management of schizophrenia.

Sprague DA, Loewen PS, Raymond CB.

Ann Pharmacother. 2004 Feb;38(2):313-9. Epub 2003 Dec 30. Review.

PMID:
14742771
[PubMed - indexed for MEDLINE]
8.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
10.

Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.

Leucht S, Pitschel-Walz G, Engel RR, Kissling W.

Am J Psychiatry. 2002 Feb;159(2):180-90.

PMID:
11823257
[PubMed - indexed for MEDLINE]
11.

Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de Hert M, Falkai P, Kapur S, Leucht S, Licht R, Naber D, O'Keane V, Papakostas G, Vieta E, Zohar J.

Eur Neuropsychopharmacol. 2009 Jul;19(7):520-32. doi: 10.1016/j.euroneuro.2009.04.003. Epub 2009 May 2.

PMID:
19411165
[PubMed - indexed for MEDLINE]
12.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
[PubMed - indexed for MEDLINE]
13.

Atypical antipsychotic agents: a critical review.

Worrel JA, Marken PA, Beckman SE, Ruehter VL.

Am J Health Syst Pharm. 2000 Feb 1;57(3):238-55. Review.

PMID:
10674777
[PubMed - indexed for MEDLINE]
14.

Haloperidol dose when used as active comparator in randomized controlled trials with atypical antipsychotics in schizophrenia: comparison with officially recommended doses.

Hugenholtz GW, Heerdink ER, Stolker JJ, Meijer WE, Egberts AC, Nolen WA.

J Clin Psychiatry. 2006 Jun;67(6):897-903. Review.

PMID:
16848649
[PubMed - indexed for MEDLINE]
15.

Quetiapine. A review of its use in the management of schizophrenia.

Cheer SM, Wagstaff AJ.

CNS Drugs. 2004;18(3):173-99. Review.

PMID:
14871161
[PubMed - indexed for MEDLINE]
16.

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis.

Leucht S, Wahlbeck K, Hamann J, Kissling W.

Lancet. 2003 May 10;361(9369):1581-9. Review.

PMID:
12747876
[PubMed - indexed for MEDLINE]
17.

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Newcomer JW.

CNS Drugs. 2005;19 Suppl 1:1-93. Review.

PMID:
15998156
[PubMed - indexed for MEDLINE]
18.

Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.

Toren P, Ratner S, Laor N, Weizman A.

Drug Saf. 2004;27(14):1135-56. Review.

PMID:
15554747
[PubMed - indexed for MEDLINE]
19.

Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials.

Stahl SM.

J Clin Psychiatry. 1999;60 Suppl 10:31-41. Review.

PMID:
10340685
[PubMed - indexed for MEDLINE]
20.

Efficacy of newer generation antipsychotics in the treatment of schizophrenia.

Tandon R, Jibson MD.

Psychoneuroendocrinology. 2003 Jan;28 Suppl 1:9-26. Review.

PMID:
12504069
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk